Signet Investment Advisory Group Inc. Has $3.35 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Signet Investment Advisory Group Inc. grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 2.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,623 shares of the healthcare conglomerate’s stock after purchasing an additional 136 shares during the quarter. UnitedHealth Group comprises approximately 1.7% of Signet Investment Advisory Group Inc.’s investment portfolio, making the stock its 22nd biggest position. Signet Investment Advisory Group Inc.’s holdings in UnitedHealth Group were worth $3,350,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. AlphaMark Advisors LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth $30,000. RPg Family Wealth Advisory LLC bought a new stake in UnitedHealth Group in the 3rd quarter valued at about $37,000. Friedenthal Financial bought a new position in shares of UnitedHealth Group during the third quarter worth approximately $51,000. DecisionPoint Financial LLC grew its position in UnitedHealth Group by 155.0% during the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after buying an additional 62 shares in the last quarter. Finally, Highline Wealth Partners LLC acquired a new position in UnitedHealth Group in the 3rd quarter valued at $55,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction dated Friday, January 17th. The stock was bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Trading Up 0.1 %

NYSE UNH opened at $533.99 on Wednesday. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $491.42 billion, a PE ratio of 34.45, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61. The business’s 50-day moving average price is $527.67 and its two-hundred day moving average price is $564.22.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the business earned $5.83 EPS. The company’s revenue was up 6.8% compared to the same quarter last year. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the company. Wells Fargo & Company dropped their price target on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Stephens upped their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a research report on Friday, January 10th. Morgan Stanley lowered their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Finally, KeyCorp reaffirmed an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. One investment analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.